Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21718817.
- Also identified by DOI 10.1016/j.athoracsur.2011.02.081.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HeartWare continuous flow ventricular assist devices (HVAD) configured as biventricular assist devices maintain diurnal flow variation, lead to end-organ recovery, and provide for a successful bridge-to-heart transplantation in the first successful North American use of continuous flow biventricular assist devices.
Medical subject headings
- Heart Transplantation
- Heart-Assist Devices
- Shock, Cardiogenic
- Ventricular Remodeling